Delivery Order SPE2DB24D2205-SPE2DB25FDXAM
Award Date
1/16/25
Potential Completion Date
1/17/25
Potential Value
$1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566760943 - LIALDA DR 1.2 GM TABLET 120S, a prescription medication. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,922.17 and a completion date of December 19, 2024. The award is not designated as a set-aside contract. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,714.39 firm fixed-price delivery order is for the supply of LIALDA DR 1.2 GM TABLET 120S, a pharmaceutical product. The contract has an ultimate completion date of October 13, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $22,741.55, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4,566,065,418 tablets of the prescription medication Lialda, a 1.2 gram delayed-release tablet, in quantities of 120 per package. This is a firm-fixed price delivery order contract with an ultimate completion date of October 10, 2024. The contract does not have a set-aside designation. Amerisourcebergen...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $3,300.51, is a Delivery Order for the medical product "LIALDA DR 1.2 GM TABLET 120S". The contract has a Firm Fixed Price pricing type and an ultimate completion date of December 16, 2024. This award is not designated as a set-aside contract. Amerisourcebergen holds...
This federal contract award is for the delivery of 4554358172 LIALDA DR 1.2 GM TABLET 120S to the Defense Logistics Agency (DLA). The contract, valued at $3,773.23, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on August 9, 2021 with an ultimate completion date of August 10, 2021. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award, valued at $82,956.27, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA, which is valued at $999,999,999 and runs through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This federal contract award, with ID SPE2DX15D6028, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $97,264.05 firm fixed-price delivery order is for 4534482086 units of LIALDA 1.2GM 1440S, a pharmaceutical product. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans'...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of 4,566,150 units of the prescription drug Lialda (mesalamine) in 120-count tablet bottles. The $2,807.73 firm fixed-price contract has an ultimate completion date of October 21, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle...
This federal contract award, with identification number SPE2DB20D1109|SPE2DB22FN14N, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $15,670.47 firm-fixed-price delivery order is for the supply of 120 tablets of the medication Lialda (mesalamine) 1.2 g. This award is part of a larger Indefinite Delivery Contract (IDC) held by the parent company Cencora, Inc., doing business as AmerisourceBergen, with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation, is a Firm Fixed Price Delivery Order (SPE2DX22F82WN) issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense. The contract, valued at $7,690.72, is for the delivery of Lialda tablets, a medication used to treat ulcerative colitis. This award is part of a larger Indefinite Delivery Contract...